查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1855954

2025年全球照護現場血脂檢測市場報告

Point Of Care Lipid Test Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，照護現場，預計將從2024年的6.8億美元成長到2025年的7.4億美元，複合年成長率達9.9%。這段歷史性成長時期主要受以下因素驅動：心血管疾病和血脂異常症盛行率上升、多參數和多重檢測技術的普及、醫療保健支出和報銷支持的增加、人們對預防保健的認知和重視程度不斷提高，以及零售藥局、診所和社區的廣泛應用。

預計未來幾年，照護現場血脂檢測市場將維持強勁成長，2029年市場規模將達到10.7億美元，複合年成長率（CAGR）為9.5%。預測期內的成長主要受以下因素驅動：家庭和自我監測場景下檢測技術的普及、人們對遺傳性血脂異常症的認知和篩檢不斷提高、慢性病負擔日益加重、醫療模式轉變為價值導向模式以及耗材需求穩定。預測期內的關鍵趨勢包括：行動科技的進步、與數位健康系統的整合、遠端患者監護和遠端醫療平台的應用、物聯網醫療（IoMT）和連線健診的整合，以及邊緣運算和低功耗生物感測器晶片的發展。

照護現場血脂檢測是一種快速診斷檢測，無需將樣本送往中心實驗室，即可透過指尖血液樣本測量膽固醇和三酸甘油酯水平，從而提供快速結果，以支持心血管風險評估和持續監測。

主要產品類型包括儀器、耗材及其他。儀器包括攜帶式分析儀和檢測設備，旨在為患者在照護端或附近快速評估血脂譜，例如膽固醇和三酸甘油酯水平。這些解決方案適用於高血脂症、高三酸甘油脂血症、唐吉爾氏症、高脂蛋白血症和遺傳性高膽固醇症等疾病。主要終端使用者包括醫院、診所、診斷實驗室和居家醫療保健機構。

美國關稅的快速上漲以及隨之而來的2025年春季貿易摩擦，正對醫療設備產業產生重大影響，尤其是進口診斷影像設備零件、手術用不銹鋼和塑膠耗材。醫院和診所都在抵制價格上漲，這擠壓了製造商的淨利率。監管障礙加劇了這個問題，因為與關稅相關的供應商變更通常需要重新認證設備，從而延緩產品上市時間。企業正透過關鍵零件的雙重採購、擴大國內同質化產品的生產以及加速研發經濟高效材料來降低風險。

本研究報告是商業研究公司（The Business Research Company）全新系列報告的一部分，提供照護現場血脂檢測市場統計數據，包括全球市場規模、區域佔有率、競爭對手及其市場佔有率、照護現場的照護現場、市場趨勢以及商機，照護現場。本照護現場照護現場檢測市場研究報告對產業現狀及未來發展趨勢進行了深入分析，為您提供所需的全面觀點。

心血管疾病盛行率的不斷上升預計將推動照護現場血脂檢測市場的成長。心血管疾病包括影響心臟和血管的疾病，例如冠狀動脈疾病、中風和高血壓，這些疾病通常由動脈粥狀硬化引起，而動脈粥狀硬化又與膽固醇和三酸甘油酯水平異常有關。心血管疾病發生率的上升主要是由於久坐不動的生活方式和體力活動減少，這會導致肥胖、血液循環不良和其他危險因子。即時血脂檢測在應對這一趨勢中發揮關鍵作用，它可以快速現場測量膽固醇和血脂水平，從而實現早期風險檢測和及時干預，防止併發症的發生。例如，美國心臟協會報告稱，2024年1月，心血管疾病死亡人數為931,578人，比前一年增加了3,000人。心血管疾病負擔的加重正在推動對照護現場血脂檢測的需求。

即時血脂檢測市場的主要企業正致力於開發先進的診斷平台，以改善臨床決策和病患管理。這些平台是可攜式整合設備，可在患者床邊快速進行實驗室級的血脂檢查，從而實現即時決策和即時治療。例如，2023年7月，總部位於加拿大的健康科技公司Vital Biosciences推出了其VitalOne平台。這款可攜式設備可在診所和藥房等場所，僅需20分鐘即可提供超過50种血液檢測的實驗室級結果。該平台將血液學、臨床化學和免疫檢測整合於一台儀器中，使醫護人員能夠在一次就診中完成檢測、診斷和治療。這項技術創新提高了患者照護的可及性、速度和個人化程度，同時保持了與傳統臨床檢測相當的準確性。

2023年5月，美國即時檢測設備製造商PTS Diagnostics與法國BIOSYNEX SA公司達成合作，旨在提升全球慢性疾病患者的醫療服務水準。此次合作旨在拓展即時血脂和糖化血紅蛋白（A1C）檢測服務，並改善全球心血管疾病和糖尿病的診療水平。 BIOSYNEX總部位於法國，專注於快速診斷檢測產品的研發和銷售，其中包括照護現場血脂檢測解決方案。

照護現場血脂檢測市場由血脂檢測、診斷支援服務、居家檢測服務和技術支援服務等服務提供者所獲得的收入所構成。市場價值還包括服務提供者銷售的或包含在其服務產品中的相關產品的價值。照護現場血脂檢測市場涵蓋試紙、血脂分析儀、手持式血脂檢測設備、膽固醇檢測設備、多參數檢測設備、採血針、品控液、試劑組、無線血脂檢測設備和藍牙血脂監測儀的銷售。這代表了產品製造商或生產商向其他營業單位（包括下游製造商、批發商、經銷商和零售商）或直接向終端客戶銷售的產品價值。該市場的產品價值還包括產品製造商銷售的任何相關服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅，以及新冠疫情及其復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球照護現場血脂檢測：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 終端用戶產業分析
  • 全球照護現場血脂檢測市場：成長率分析
  • 全球照護現場血脂檢測市場表現：規模與成長，2019-2024年
  • 全球照護現場血脂檢測市場預測：規模與成長，2024-2029年，2034年預測
  • 全球照護現場血脂檢測：潛在市場規模 (TAM)

第6章 市場細分

  • 全球照護現場，2019-2024年、2024-2029年預測、2034年預測
  • 測量設備
  • 消耗品
  • 其他產品類型
  • 全球照護現場血脂檢測市場：依應用、效能和預測分類，2019-2024年、2024-2029年預測、2034年預測
  • 高血脂症
  • 高三酸甘油脂血症
  • 唐吉爾氏症
  • 高脂蛋白血症
  • 遺傳性高膽固醇症
  • 其他用途
  • 全球照護現場，實際數據及預測數據，2019-2024年、2024-2029年預測數據、2034年預測數據
  • 醫院
  • 診所
  • 診斷實驗室
  • 家庭護理機構
  • 其他最終用戶
  • 全球照護現場血脂檢測市場：按設備、類型、性能和預測進行細分，2019-2024年、2024-2029年預測、2034年預測
  • 桌上型分析儀
  • 可攜式或手持式分析儀
  • 多參數分析儀
  • 單參數分析儀
  • 全球照護現場血脂檢測市場：按耗材、類型、實際值和預測值分類的細分市場，2019-2024年、2024-2029年預測值、2034年預測值
  • 試紙
  • 試劑和套件
  • 品管材料
  • 校準器
  • 全球照護現場血脂檢測市場：依產品類型細分，依類型分類，實際值及預測值（2019-2024年、2024-2029年預測值、2034年預測值）。
  • 軟體解決方案
  • 配件
  • 資料管理和連接工具

第7章 區域和國家分析

  • 全球照護現場血脂檢測市場：區域分析、預測及趨勢（2019-2024年、2024-2029年預測、2034年預測）
  • 全球照護現場血脂檢測市場：國家、市場表現及預測，2019-2024年、2024-2029年預測、2034年預測

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章：西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章：俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 照護現場血脂檢測市場：競爭格局
  • 照護現場血脂檢測市場：公司概況
    • F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
    • Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
    • Quidel Corporation Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

  • Bio-Rad Laboratories Inc.
  • Horiba ABX SAS
  • Randox Laboratories Ltd.
  • Sekisui Diagnostics LLC
  • Fisher Scientific International Inc.
  • Everlywell Inc.
  • EKF Diagnostics Holdings plc
  • Trinity Biotech plc
  • VivaChek Biotech（Hangzhou）Co. Ltd.
  • EuroMedix International NV
  • A. Menarini Industrie Farmaceutiche Riunite Srl
  • AccuBioTech Co. Ltd.
  • Callegari Srl
  • MiCo BioMed Co. Ltd.
  • BHR Diagnostics Private Limited

第32章 全球市場競爭基準化分析與儀錶板

第33章 重大併購

第34章 近期市場趨勢

第35章：高潛力市場國家、細分市場與策略

  • 2029年照護現場血脂檢測市場：提供新機會的國家
  • 2029年照護現場血脂檢測市場：充滿新機會的細分市場
  • 照護現場血脂檢測市場2029年：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章附錄

簡介目錄
Product Code: r38606

A point of care lipid test is a rapid diagnostic test that uses a fingerstick blood sample to measure cholesterol and triglyceride levels without sending samples to a central laboratory. It provides fast results to support cardiovascular risk assessment and ongoing monitoring.

The primary product types of point of care lipid tests are instruments, consumables, and others. Instruments include portable analyzers and testing devices designed to quickly assess lipid profiles, such as cholesterol and triglyceride levels, at or near the patient care site. These solutions are applied in conditions such as hyperlipidemia, hypertriglyceridemia, Tangier disease, hyperlipoproteinemia, familial hypercholesterolemia, and others. Key end users include hospitals, clinics, diagnostic laboratories, home care settings, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers' margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

The point of care lipid test market research report is one of a series of new reports from The Business Research Company that provides point of care lipid test market statistics, including the point of care lipid test industry global market size, regional shares, competitors with the point of care lipid test market share, detailed point of care lipid test market segments, market trends, and opportunities, and any further data you may need to thrive in the point of care lipid test industry. This point of care lipid test market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The point of care lipid test market size has grown strongly in recent years. It will grow from $0.68 billion in 2024 to $0.74 billion in 2025 at a compound annual growth rate (CAGR) of 9.9%. The growth during the historic period was driven by the rising prevalence of cardiovascular disease and dyslipidemia, expansion of multi-analyte and multiplex testing, increasing healthcare expenditure and reimbursement support, growing awareness and focus on preventive healthcare, and wider adoption in retail pharmacies, clinics, and community settings.

The point of care lipid test market size is expected to see strong growth in the next few years. It will grow to $1.07 billion in 2029 at a compound annual growth rate (CAGR) of 9.5%. The growth during the forecast period is fueled by increasing adoption in home based and self-monitoring settings, rising awareness and screening for genetic lipid disorders, growing chronic disease burden, the shift toward value based healthcare models, and stable demand for consumables. The primary trends in the forecast period include advancements in portable technology, integration with digital health systems, incorporation into remote patient monitoring and telemedicine platforms, integration within IoMT or connected health infrastructure, and development of edge computing and low-power biosensor chips.

The growing prevalence of cardiovascular diseases is expected to drive the growth of the point-of-care lipid test market. Cardiovascular diseases encompass conditions affecting the heart and blood vessels, such as coronary artery disease, stroke, and hypertension, often resulting from atherosclerosis linked to abnormal cholesterol and triglyceride levels. The rise in cardiovascular diseases is largely due to sedentary lifestyles and decreased physical activity, leading to obesity, poor circulation, and other risk factors. Point-of-care lipid tests play a crucial role in managing this trend by offering rapid, on-site measurement of cholesterol and lipid levels, enabling early identification of risk and timely intervention to prevent further complications. For example, the American Heart Association reported in January 2024 that cardiovascular diseases caused 931,578 deaths, a rise of 3,000 compared to the previous year. This increasing burden of cardiovascular diseases is driving the demand for point-of-care lipid tests.

Leading companies in the point-of-care lipid test market are focusing on advanced diagnostic platforms to improve clinical decision-making and patient management. These platforms are portable, integrated devices capable of performing rapid, lab-quality lipid panel tests at the patient's bedside, allowing real-time decision-making and immediate treatment. For example, in July 2023, Vital Biosciences Inc., a health tech company based in Canada, introduced the VitalOne platform. This portable device delivers over 50 lab-grade blood test results in just 20 minutes at locations such as clinics and pharmacies. The platform combines hematology, clinical chemistry, and immunoassays in one device, enabling healthcare providers to perform testing, diagnosis, and treatment during a single visit. This innovation improves access, speed, and personalization of patient care, while maintaining accuracy comparable to traditional laboratory tests.

In May 2023, PTS Diagnostics, a US-based manufacturer of point-of-care testing devices, partnered with BIOSYNEX S.A. to enhance care for patients with chronic diseases worldwide. The collaboration aims to expand their point-of-care lipid and A1C testing services, improving cardiovascular and diabetes care on a global scale. BIOSYNEX, based in France, specializes in developing and distributing rapid diagnostic tests, including point-of-care lipid testing solutions.

Major players in the point of care lipid test market are F. Hoffmann-La Roche Ltd., Abbott Laboratories, Siemens Healthineers AG, Becton Dickinson and Company, Quidel Corporation, Bio-Rad Laboratories Inc., Horiba ABX SAS, Randox Laboratories Ltd., Sekisui Diagnostics LLC, Fisher Scientific International Inc., Everlywell Inc., EKF Diagnostics Holdings plc, Trinity Biotech plc, VivaChek Biotech (Hangzhou) Co. Ltd., EuroMedix International NV, A. Menarini Industrie Farmaceutiche Riunite S.r.l., AccuBioTech Co. Ltd., Callegari S.r.l., MiCo BioMed Co. Ltd., BHR Diagnostics Private Limited.

North America was the largest region in the point of care lipid test market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in point of care lipid test report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the point of care lipid test market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The point of care lipid test market consists of revenues earned by entities by providing services such as lipid profile testing services, diagnostic support services, home-based testing services, and technical support services. The market value includes the value of related goods sold by the service provider or included within the service offering. The point of care lipid test market includes the sale of test strips, lipid panel analyzers, handheld lipid testing devices, cholesterol testing devices, multi-parameter testing devices, lancets, control solutions, reagent kits, wireless lipid testing devices, and Bluetooth-enabled lipid monitors. Values in this market are 'factory gate' values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Point Of Care Lipid Test Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on point of care lipid test market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for point of care lipid test ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The point of care lipid test market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product Types: Instruments; Consumables; Other Product Types
  • 2) By Application: Hyperlipidemia; Hypertriglyceridemia; Tangier Disease; Hyperlipoproteinemia; Familial Hypercholesterolemia; Other Applications
  • 3) By End-User: Hospitals; Clinics; Diagnostic Laboratories; Home Care Settings; Other End Users
  • Subsegments:
  • 1) By Instruments: Benchtop Analyzers; Portable Or Handheld Analyzers; Multi-parameter Analyzers; Single-parameter Analyzers
  • 2) By Consumables: Test Strips; Reagents And Kits; Quality Control Materials; Calibrators
  • 3) By Other Product Types: Software Solutions; Accessories; Data Management And Connectivity Tools
  • Companies Mentioned: F. Hoffmann-La Roche Ltd.; Abbott Laboratories; Siemens Healthineers AG; Becton Dickinson and Company; Quidel Corporation; Bio-Rad Laboratories Inc.; Horiba ABX SAS; Randox Laboratories Ltd.; Sekisui Diagnostics LLC; Fisher Scientific International Inc.; Everlywell Inc.; EKF Diagnostics Holdings plc; Trinity Biotech plc; VivaChek Biotech (Hangzhou) Co. Ltd.; EuroMedix International NV; A. Menarini Industrie Farmaceutiche Riunite S.r.l.; AccuBioTech Co. Ltd.; Callegari S.r.l.; MiCo BioMed Co. Ltd.; BHR Diagnostics Private Limited
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Point Of Care Lipid Test Market Characteristics

3. Point Of Care Lipid Test Market Trends And Strategies

4. Point Of Care Lipid Test Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Point Of Care Lipid Test Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Point Of Care Lipid Test PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Point Of Care Lipid Test Market Growth Rate Analysis
  • 5.4. Global Point Of Care Lipid Test Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Point Of Care Lipid Test Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Point Of Care Lipid Test Total Addressable Market (TAM)

6. Point Of Care Lipid Test Market Segmentation

  • 6.1. Global Point Of Care Lipid Test Market, Segmentation By Product Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Instruments
  • Consumables
  • Other Product Types
  • 6.2. Global Point Of Care Lipid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hyperlipidemia
  • Hypertriglyceridemia
  • Tangier Disease
  • Hyperlipoproteinemia
  • Familial Hypercholesterolemia
  • Other Applications
  • 6.3. Global Point Of Care Lipid Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Clinics
  • Diagnostic Laboratories
  • Home Care Settings
  • Other End Users
  • 6.4. Global Point Of Care Lipid Test Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Benchtop Analyzers
  • Portable Or Handheld Analyzers
  • Multi-parameter Analyzers
  • Single-parameter Analyzers
  • 6.5. Global Point Of Care Lipid Test Market, Sub-Segmentation Of Consumables, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Test Strips
  • Reagents And Kits
  • Quality Control Materials
  • Calibrators
  • 6.6. Global Point Of Care Lipid Test Market, Sub-Segmentation Of Other Product Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Software Solutions
  • Accessories
  • Data Management And Connectivity Tools

7. Point Of Care Lipid Test Market Regional And Country Analysis

  • 7.1. Global Point Of Care Lipid Test Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Point Of Care Lipid Test Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Point Of Care Lipid Test Market

  • 8.1. Asia-Pacific Point Of Care Lipid Test Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Point Of Care Lipid Test Market, Segmentation By Product Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Point Of Care Lipid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Point Of Care Lipid Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Point Of Care Lipid Test Market

  • 9.1. China Point Of Care Lipid Test Market Overview
  • 9.2. China Point Of Care Lipid Test Market, Segmentation By Product Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Point Of Care Lipid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Point Of Care Lipid Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Point Of Care Lipid Test Market

  • 10.1. India Point Of Care Lipid Test Market, Segmentation By Product Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Point Of Care Lipid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Point Of Care Lipid Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Point Of Care Lipid Test Market

  • 11.1. Japan Point Of Care Lipid Test Market Overview
  • 11.2. Japan Point Of Care Lipid Test Market, Segmentation By Product Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Point Of Care Lipid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Point Of Care Lipid Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Point Of Care Lipid Test Market

  • 12.1. Australia Point Of Care Lipid Test Market, Segmentation By Product Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Point Of Care Lipid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Point Of Care Lipid Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Point Of Care Lipid Test Market

  • 13.1. Indonesia Point Of Care Lipid Test Market, Segmentation By Product Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Point Of Care Lipid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Point Of Care Lipid Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Point Of Care Lipid Test Market

  • 14.1. South Korea Point Of Care Lipid Test Market Overview
  • 14.2. South Korea Point Of Care Lipid Test Market, Segmentation By Product Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Point Of Care Lipid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Point Of Care Lipid Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Point Of Care Lipid Test Market

  • 15.1. Western Europe Point Of Care Lipid Test Market Overview
  • 15.2. Western Europe Point Of Care Lipid Test Market, Segmentation By Product Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Point Of Care Lipid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Point Of Care Lipid Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Point Of Care Lipid Test Market

  • 16.1. UK Point Of Care Lipid Test Market, Segmentation By Product Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Point Of Care Lipid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Point Of Care Lipid Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Point Of Care Lipid Test Market

  • 17.1. Germany Point Of Care Lipid Test Market, Segmentation By Product Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Point Of Care Lipid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Point Of Care Lipid Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Point Of Care Lipid Test Market

  • 18.1. France Point Of Care Lipid Test Market, Segmentation By Product Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Point Of Care Lipid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Point Of Care Lipid Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Point Of Care Lipid Test Market

  • 19.1. Italy Point Of Care Lipid Test Market, Segmentation By Product Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Point Of Care Lipid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Point Of Care Lipid Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Point Of Care Lipid Test Market

  • 20.1. Spain Point Of Care Lipid Test Market, Segmentation By Product Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Point Of Care Lipid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Point Of Care Lipid Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Point Of Care Lipid Test Market

  • 21.1. Eastern Europe Point Of Care Lipid Test Market Overview
  • 21.2. Eastern Europe Point Of Care Lipid Test Market, Segmentation By Product Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Point Of Care Lipid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Point Of Care Lipid Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Point Of Care Lipid Test Market

  • 22.1. Russia Point Of Care Lipid Test Market, Segmentation By Product Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Point Of Care Lipid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Point Of Care Lipid Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Point Of Care Lipid Test Market

  • 23.1. North America Point Of Care Lipid Test Market Overview
  • 23.2. North America Point Of Care Lipid Test Market, Segmentation By Product Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Point Of Care Lipid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Point Of Care Lipid Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Point Of Care Lipid Test Market

  • 24.1. USA Point Of Care Lipid Test Market Overview
  • 24.2. USA Point Of Care Lipid Test Market, Segmentation By Product Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Point Of Care Lipid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Point Of Care Lipid Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Point Of Care Lipid Test Market

  • 25.1. Canada Point Of Care Lipid Test Market Overview
  • 25.2. Canada Point Of Care Lipid Test Market, Segmentation By Product Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Point Of Care Lipid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Point Of Care Lipid Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Point Of Care Lipid Test Market

  • 26.1. South America Point Of Care Lipid Test Market Overview
  • 26.2. South America Point Of Care Lipid Test Market, Segmentation By Product Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Point Of Care Lipid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Point Of Care Lipid Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Point Of Care Lipid Test Market

  • 27.1. Brazil Point Of Care Lipid Test Market, Segmentation By Product Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Point Of Care Lipid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Point Of Care Lipid Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Point Of Care Lipid Test Market

  • 28.1. Middle East Point Of Care Lipid Test Market Overview
  • 28.2. Middle East Point Of Care Lipid Test Market, Segmentation By Product Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Point Of Care Lipid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Point Of Care Lipid Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Point Of Care Lipid Test Market

  • 29.1. Africa Point Of Care Lipid Test Market Overview
  • 29.2. Africa Point Of Care Lipid Test Market, Segmentation By Product Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Point Of Care Lipid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Point Of Care Lipid Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Point Of Care Lipid Test Market Competitive Landscape And Company Profiles

  • 30.1. Point Of Care Lipid Test Market Competitive Landscape
  • 30.2. Point Of Care Lipid Test Market Company Profiles
    • 30.2.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Quidel Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Point Of Care Lipid Test Market Other Major And Innovative Companies

  • 31.1. Bio-Rad Laboratories Inc.
  • 31.2. Horiba ABX SAS
  • 31.3. Randox Laboratories Ltd.
  • 31.4. Sekisui Diagnostics LLC
  • 31.5. Fisher Scientific International Inc.
  • 31.6. Everlywell Inc.
  • 31.7. EKF Diagnostics Holdings plc
  • 31.8. Trinity Biotech plc
  • 31.9. VivaChek Biotech (Hangzhou) Co. Ltd.
  • 31.10. EuroMedix International NV
  • 31.11. A. Menarini Industrie Farmaceutiche Riunite S.r.l.
  • 31.12. AccuBioTech Co. Ltd.
  • 31.13. Callegari S.r.l.
  • 31.14. MiCo BioMed Co. Ltd.
  • 31.15. BHR Diagnostics Private Limited

32. Global Point Of Care Lipid Test Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Point Of Care Lipid Test Market

34. Recent Developments In The Point Of Care Lipid Test Market

35. Point Of Care Lipid Test Market High Potential Countries, Segments and Strategies

  • 35.1 Point Of Care Lipid Test Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Point Of Care Lipid Test Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Point Of Care Lipid Test Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer